Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhruva Katrekar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochemistry|April 4, 2019
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA EditingGenghao Chen, Dhruva Katrekar, Prashant Mali
Methods (San Diego, Calif.)|July 2, 2022
Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editingYichen Xiang, Dhruva Katrekar, Prashant Mali
Scientific Reports|February 28, 2018
Oligonucleotide conjugated multi-functional adeno-associated virusesDhruva Katrekar, Ana M Moreno, Genghao Chen, et al.
Elife|January 19, 2022
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificityDhruva Katrekar, Yichen Xiang, Nathan Palmer, et al.
Nature Biotechnology|February 11, 2022
Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAsDhruva Katrekar, James Yen, Yichen Xiang, et al.
Nature Methods|February 10, 2019
In vivo RNA editing of point mutations via RNA-guided adenosine deaminasesDhruva Katrekar, Genghao Chen, Dario Meluzzi, et al.
Stem Cell Reports|September 24, 2021
Programmatic introduction of parenchymal cell types into blood vessel organoidsAmir Dailamy, Udit Parekh, Dhruva Katrekar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2023
RNA editing: Expanding the potential of RNA therapeuticsBrian J Booth, Sami Nourreddine, Dhruva Katrekar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2018
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene RegulationAna M Moreno, Xin Fu, Jie Zhu, et al.
Science (New York, N.Y.)|September 25, 2025
Megabase-scale human genome rearrangement with programmable bridge recombinasesNicholas T Perry, Liam J Bartie, Dhruva Katrekar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochemistry|April 4, 2019
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA EditingGenghao Chen, Dhruva Katrekar, Prashant Mali
Methods (San Diego, Calif.)|July 2, 2022
Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editingYichen Xiang, Dhruva Katrekar, Prashant Mali
Scientific Reports|February 28, 2018
Oligonucleotide conjugated multi-functional adeno-associated virusesDhruva Katrekar, Ana M Moreno, Genghao Chen, et al.
Elife|January 19, 2022
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificityDhruva Katrekar, Yichen Xiang, Nathan Palmer, et al.
Nature Biotechnology|February 11, 2022
Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAsDhruva Katrekar, James Yen, Yichen Xiang, et al.
Nature Methods|February 10, 2019
In vivo RNA editing of point mutations via RNA-guided adenosine deaminasesDhruva Katrekar, Genghao Chen, Dario Meluzzi, et al.
Stem Cell Reports|September 24, 2021
Programmatic introduction of parenchymal cell types into blood vessel organoidsAmir Dailamy, Udit Parekh, Dhruva Katrekar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2023
RNA editing: Expanding the potential of RNA therapeuticsBrian J Booth, Sami Nourreddine, Dhruva Katrekar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2018
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene RegulationAna M Moreno, Xin Fu, Jie Zhu, et al.
Science (New York, N.Y.)|September 25, 2025
Megabase-scale human genome rearrangement with programmable bridge recombinasesNicholas T Perry, Liam J Bartie, Dhruva Katrekar, et al.
Pageof 2